Zomedica Corp. (ZOMDF) stock
ZOMDFOTCPharmaceutical PreparationsFiscal year ends December 31
$0.08−0.00 (-0.55%)
Close on Oct 19, 2026Market cap $77.40MP/E –Yield –
Zomedica total assets
Total assets on the balance sheet at the end of each period.
Zomedica's total assets was $118.15M at Jun 30, 2026. For fiscal 2025 it was $127.04M, down 38.7% from the year before. The highest annual figure on record is $280.40M in fiscal 2021.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $127.04M | -38.7% |
| FY2024 | Dec 31, 2024 | $207.36M | -18.1% |
| FY2023 | Dec 31, 2023 | $253.20M | -9.4% |
| FY2022 | Dec 31, 2022 | $279.61M | -0.3% |
| FY2021 | Dec 31, 2021 | $280.40M | +323.9% |
| FY2020 | Dec 31, 2020 | $66.14M | +1481.3% |
| FY2019 | Dec 31, 2019 | $4.18M | -30.7% |
| FY2018 | Dec 31, 2018 | $6.03M | +15.7% |
| FY2017 | Dec 31, 2017 | $5.22M | +14.0% |
| FY2016 | Dec 31, 2016 | $4.58M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $118.15M | -13.4% |
| Q1 FY2026 | Mar 31, 2026 | $121.53M | -15.0% |
| Q4 FY2025 | Dec 31, 2025 | $127.04M | -38.7% |
| Q3 FY2025 | Sep 30, 2025 | $130.91M | -38.9% |
| Q2 FY2025 | Jun 30, 2025 | $136.47M | -37.9% |
| Q1 FY2025 | Mar 31, 2025 | $142.99M | -41.3% |
| Q4 FY2024 | Dec 31, 2024 | $207.36M | -18.1% |
| Q3 FY2024 | Sep 30, 2024 | $214.12M | -22.2% |
| Q2 FY2024 | Jun 30, 2024 | $219.88M | -20.0% |
| Q1 FY2024 | Mar 31, 2024 | $243.70M | -12.8% |
| Q4 FY2023 | Dec 31, 2023 | $253.20M | -9.4% |
| Q3 FY2023 | Sep 30, 2023 | $275.05M | -2.6% |
| Q2 FY2023 | Jun 30, 2023 | $274.78M | -0.3% |
| Q1 FY2023 | Mar 31, 2023 | $279.60M | +0.6% |
| Q4 FY2022 | Dec 31, 2022 | $279.61M | -0.3% |
| Q3 FY2022 | Sep 30, 2022 | $282.30M | +1.7% |
| Q2 FY2022 | Jun 30, 2022 | $275.48M | -1.7% |
| Q1 FY2022 | Mar 31, 2022 | $277.99M | -0.9% |
| Q4 FY2021 | Dec 31, 2021 | $280.40M | +323.9% |
| Q3 FY2021 | Sep 30, 2021 | $277.50M | +390.2% |
| Q2 FY2021 | Jun 30, 2021 | $280.35M | +755.7% |
| Q1 FY2021 | Mar 31, 2021 | $280.47M | +5470.9% |
| Q4 FY2020 | Dec 31, 2020 | $66.14M | +1481.3% |
| Q3 FY2020 | Sep 30, 2020 | $56.60M | +756.2% |
| Q2 FY2020 | Jun 30, 2020 | $32.76M | +245.6% |
| Q1 FY2020 | Mar 31, 2020 | $5.03M | -14.6% |
| Q4 FY2019 | Dec 31, 2019 | $4.18M | -30.7% |
| Q3 FY2019 | Sep 30, 2019 | $6.61M | +57.8% |
| Q2 FY2019 | Jun 30, 2019 | $9.48M | +47.7% |
| Q1 FY2019 | Mar 31, 2019 | $5.89M | +20.4% |
| Q4 FY2018 | Dec 31, 2018 | $6.03M | +15.7% |
| Q3 FY2018 | Sep 30, 2018 | $4.19M | -8.4% |
| Q2 FY2018 | Jun 30, 2018 | $6.42M | – |
| Q1 FY2018 | Mar 31, 2018 | $4.90M | – |
| Q4 FY2017 | Dec 31, 2017 | $5.22M | – |
| Q4 FY2016 | Dec 31, 2016 | $4.58M | – |
See a number that looks wrong?